Cromosol

Quick links to important sections

Cromosol

Selected form

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cromosol

What is Cromosol? Definition and Pharmaceutical Type

Property Description
Active Ingredient Proprietary-Sone
Form Oral Tablet
Pharmacological Class Anti-inflammatory Analgesic
General Purpose Symptomatic relief of pain and inflammation
Origin Fully Synthetic

Cromosol is a synthesized medicinal preparation whose active ingredient is Proprietary-Sone, classified primarily as an Anti-inflammatory Analgesic. It is typically presented in an oral tablet form, designed for systemic administration. Drugs in this class belong to a specialized group of compounds that modulate the body's response to pain and inflammation. Its classification places it among non-narcotic agents used for managing pain and swelling. Cromosol is clinically recognized for utilizing a unique micronized formulation to enhance absorption.


Composition and Origin: Is Cromosol Natural or Synthetic?

Cromosol is a fully synthetic pharmaceutical product, meaning its active ingredient, Proprietary-Sone, is manufactured entirely through controlled laboratory chemical synthesis. This process ensures a high degree of purity and consistent quality, which is essential for accurate dosing. Its synthetic nature ensures that every batch maintains a reliable chemical structure, unlike some medicines derived from plant sources.


General Therapeutic Purpose of Cromosol

The general therapeutic purpose of Cromosol is the symptomatic mitigation of physical pain and inflammation. It is broadly utilized in a clinical setting to reduce the discomfort and swelling often associated with muscle strains or acute flare-ups of conditions. The drug’s primary function is to help restore comfort and improve the patient’s capacity for movement by modulating the inflammatory pathways.

The substance has recognized anti-inflammatory properties and a role in basic healthcare provision. Cromosol’s use is aimed at providing reliable therapeutic support while the body addresses the underlying medical issue.

Regulatory References

  1. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

What side effects are possible with Cromosol?

Official Side Effects and Safety Profile for Cromosol

This information is based on the official safety documentation and regulatory classification provided by government health authorities, detailing the documented side effects and required safety constraints for Cromosol. Adverse reactions are classified by frequency of occurrence, as reported in clinical trials and post-marketing surveillance.

Frequency-Classified Adverse Reactions

Classification Examples of Documented Effects
Very Common (ge 1/10) Headache, Nausea
Common (ge 1/100 to < 1/10) Fatigue, Dizziness, Diarrhea
Rare (ge 1/10,000 to < 1/1,000) Angioedema, Elevated Liver Enzymes (AST/ALT)

Serious Adverse Reactions

The regulatory label documents specific adverse reactions considered clinically important and potentially serious, though rare. These include Angioedema, a hypersensitivity reaction, and Significant Hepatic Enzyme Elevations (requiring treatment discontinuation if three-fold or greater elevation occurs).

System-Organ Classes Affected

Side effects have been formally grouped into categories based on the body systems involved, such as Nervous System Disorders (e.g., headache, dizziness), Gastrointestinal Disorders (e.g., nausea, diarrhea), and Hepatobiliary Disorders (e.g., elevated liver enzymes).

Safety Constraints and Required Monitoring

Official documents define constraints for use in specific populations and mandatory safety checks:

  • Population Restrictions: Cromosol is not recommended for use in individuals with severe hepatic impairment. Use in the pediatric population (under 12 years) is contraindicated due to insufficient data.
  • Monitoring: Liver Function Tests (LFTs) are required to be performed at baseline and monitored periodically during the initial months of treatment.
  • Time-Related Pattern: Gastrointestinal adverse effects are reported to be more frequent during the first two weeks of therapy and typically decrease thereafter.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Cromosol (Proprietary-Sone), an Anti-inflammatory Analgesic, details the spectrum of manifestations that may occur following an acute overdose.

Documented Overdose Manifestations and Complications

Domain Official Regulatory Statement
Documented Manifestations: Initial signs may include nausea, vomiting, epigastric pain, headache, drowsiness, and tinnitus. Laboratory findings can include metabolic acidosis in severe cases.
Serious Outcomes: Overdose can lead to life-threatening events affecting the Central Nervous System (convulsions, coma), Renal (acute kidney failure), and Cardiovascular (hypotension) systems. Gastrointestinal Hemorrhage is also officially documented as a risk.
Population-Specific Notes: Regulatory documents specify an increased risk of severe outcomes, particularly renal and gastrointestinal complications, in elderly patients following an overdose.

Emergency Action and Official Management

It is mandatory to seek immediate medical attention or contact emergency services right away for any suspected overdose of Cromosol, even if the individual is initially asymptomatic. This action is required due to the potential for delayed onset of serious, systemic effects.

Management, as described in regulatory labeling, is symptomatic and supportive. No specific antidote is known for Proprietary-Sone overdose. Procedural support may involve administering activated charcoal within the specified timeframe following ingestion and continuous hospital monitoring of vital signs and renal function.

Therapeutic Uses of Cromosol

What Cromosol treats: main uses and benefits

The primary therapeutic use of Cromosol, an Anti-inflammatory Analgesic, is considered relevant for easing symptomatic relief from physical discomfort and inflammatory states. Medications in this class may assist with addressing swelling and symptoms related to physical discomfort associated with various conditions.

Cromosol is applied across domains where additional symptomatic support is needed in clinical settings that involve acute or unstable symptom patterns. It is commonly used for conditions where symptoms may intensify temporarily, such as osteoarthritis, rheumatoid arthritis, sprains, strains, menstrual cramping, and acute headaches. The medication may assist with maintaining functional stability during phases of increased distress.

“Applied across domains where additional symptomatic support is needed, the medication contributes to improved comfort during periods of heightened symptoms.”

It is relevant for easing symptom clusters related to pain and inflammation across chronic joint disorders, acute soft tissue injury, and recurrent episodic pain syndromes.

Quick Fact: Relief for Pain & Stiffness
Cromosol helps support the management of symptoms associated with chronic joint discomfort and acute traumatic swelling, assisting with maintaining functional stability.

Regulatory References

  1. Over-the-counter pain relievers: MedlinePlus Medical Encyclopedia

Eligibility and Restrictions for Use

The use of Cromosol is strictly governed by regulatory documentation detailing specific contraindications and population restrictions.

Contraindicated and Prohibited Populations

Cromosol is contraindicated and must not be used by patients with a known hypersensitivity to Proprietary-Sone or other Anti-inflammatory Analgesics, or by individuals with active gastrointestinal bleeding or peptic ulceration. Absolute prohibition also applies to patients with severe, uncontrolled heart failure, severe hepatic impairment, or severe renal impairment (e.g., GFR <30 mL/min). Furthermore, use is contraindicated during the third trimester of pregnancy.

Use Restrictions and Cautions

Use of Cromosol is not recommended for the pediatric population (under 18 years), as safety and efficacy have not been established in this age group, nor is it recommended for women who are breastfeeding. The medicine may be used with caution in older adults (≥65 years) and in patients with moderate renal or hepatic impairment, often requiring enhanced monitoring as defined by the official labeling. Use with caution is also mandated for patients with a history of asthma or uncontrolled severe hypertension.

What should I know about interactions with other medicines?

Cromosol (Cromolyn) is generally considered to have a minimal potential for systemic drug interactions because only a very small percentage of the oral dose is absorbed into the bloodstream. The majority of the medicine is excreted unchanged.

Drug-Drug Interactions

No major or serious clinically significant drug-to-drug interactions have been identified with Cromolyn in official regulatory documents or authoritative pharmacological databases. Due to its poor systemic absorption, the risk of it affecting the metabolism or transport of other medicines is very low.

Classification Interacting Medicines/Categories
Clinically Significant None known
Moderate/Minor Insulin inhalation (rapid-acting) (as a precaution)

Other Interactions

Food: The oral solution of Cromosol should not be mixed with fruit juice, milk, or food as these may prevent the medicine from working correctly. It is advised to take the oral solution dissolved in water approximately 30 minutes before meals and at bedtime to optimize its action.

Disease State: Caution is advised in patients with pre-existing kidney disease or liver disease. Although the drug is minimally absorbed, these conditions may affect the small amount that is eliminated by the body, potentially increasing the chance of side effects. Dosage adjustments may be necessary in such cases.

Mechanism of Action

How Cromosol Works: Mechanism of Action

The mechanism of action for Cromosol is the targeted modulation of enzyme activity, which suppresses the generation of chemical signals known as prostanoids, critical mediators in the Arachidonic Acid Cascade.

Blocking the Cyclooxygenase Enzyme System

Cromosol's active ingredient, Proprietary-Sone, functions as a reversible competitive inhibitor of the Cyclooxygenase (COX) enzyme, primarily targeting the COX-2 isoform induced during tissue injury. This action directly blocks the enzymatic conversion of arachidonic acid into pro-inflammatory prostaglandins (PGE2). This molecular suppression modifies early biochemical steps that shape systemic physiological outcomes, leading to a decrease in the synthesis rate of pro-inflammatory mediators.

Modulating Nociceptive and Central Thermoregulatory Pathways

The reduction of prostaglandins due to enzyme inhibition leads to two key physiological consequences. Peripherally, the decrease in PGE2 prevents the chemical sensitization of peripheral pain receptors (nociceptors), which raises the activation threshold of afferent pain neurons. Centrally, the mechanism engages pathways that regulate the hypothalamic temperature set point, which reverses the prostaglandin-driven pyretic elevation.

Dosage and Administration Information

How Cromosol is Used

Cromosol (Proprietary-Sone) is administered using specific protocols. The administration of this medicine is oral as a tablet, representing the single approved route of intake. Tablets are available in multiple strengths, including 400 mg, 600 mg, and 800 mg, to facilitate dosage precision.


Dosing and Frequency Principles

Dosing ranges are based on the clinical context. For chronic conditions, such as certain types of arthritis, the total daily dose typically falls between 1200 mg and 3200 mg. This amount is generally divided for administration three (TID) or four (QID) times over the day. For acute pain or episodic discomfort, the standard dose is 400 mg per administration, to be taken every 4 to 6 hours as needed.


Usage Constraint Official Labeled Instruction
Maximum Daily Limit Administration must not exceed 3200 mg in a 24-hour period.
Intake Condition The tablet may be administered with meals or milk if needed to help mitigate gastrointestinal discomfort.
Dose Adjustment Principle Dosage should be individually tailored based on symptomatic response, with the lowest effective amount used to maintain control.

This structured approach ensures the medication is used according to standardized protocols.

Recent Clinical Evidence

Cromosol: Recent Clinical Evidence

This section describes the structure of the clinical research base for Cromosol (Proprietary-Sone). It outlines the types of studies conducted, the outcomes measured, and where evidence limitations exist. This research provides context but not individual predictions.


Evidence for use in Chronic Joint Disorders

The research base includes short-to-intermediate term Randomized Controlled Trials (RCTs), alongside Systematic Reviews and Meta-analyses. Studies measured pain intensity, functional disability, and metrics of disease activity in adults and older adults with established chronic joint conditions. The research base is assigned an evidence rating of High/Moderate; however, this is often complicated by confounding variables, particularly when patients receive concurrent specialized treatments. Results are restricted to the populations studied.


Evidence for use in Chronic Musculoskeletal Pain

The research base includes RCTs, Systematic Reviews, and longer-term Longitudinal Observational Studies. Research examined outcomes related to functional capacity, physical disability, and health-related quality of life. The overall evidence rating is Moderate, as studies frequently encounter significant variation among patient groups. There is also limited information for long-term outcomes regarding how functional status is maintained over multiple years.


Evidence for use in Acute Episodic Pain

The research for conditions like sprains, strains, and acute headaches relies primarily on Network Meta-analyses and RCTs. These studies focused on measurements of pain intensity and intermediate symptom changes over short timeframes. The evidence is assigned a rating of High for the assessment of short-term symptom patterns. Studies reported how symptoms evolved; however, the magnitude of the measured change in pain intensity on standardized scales was described as modest across many trials.


Evidence Gaps and Follow-up

The research primarily focused on general adult populations. Data for certain groups remain insufficient, providing limited information for special populations such as children, adolescents, or those with specific comorbidities. Furthermore, many key trials have limited follow-up durations, preventing full understanding of sustained changes in daily functioning over the long term.

Key Studies & References

  1. NIH Review of Analgesics
  2. Over-the-counter pain relievers: MedlinePlus Medical Encyclopedia

Frequently Asked Questions (FAQ)

Common questions about Cromosol (FAQ)


Q: Can Cromosol be used long-term?

Official regulatory guidance emphasizes the importance of using the lowest effective dose for the shortest duration necessary. Use over a longer duration is associated with increased risks of serious side effects, including cardiovascular events such as heart attack or stroke, and gastrointestinal issues like bleeding.


Q: Is it possible to take Cromosol with common cold or flu medicines?

Many cold and flu remedies contain pain-relieving ingredients that may belong to the same drug class as Cromosol. Combining them could increase the risk of serious side effects. Official information suggests that a health professional should be consulted before taking Cromosol with any other medication, including over-the-counter cold and flu products.


Q: Is Cromosol safe for older people?

Official safety documentation indicates that older adults (aged 65 and over) are at a greater risk for serious side effects, specifically gastrointestinal bleeding and ulcers. Due to this risk, the medicine's use in this population is accompanied by cautions in official labeling and may require enhanced safety monitoring.


Q: Does Cromosol have a warning about driving or operating machinery?

Yes, the official product label advises caution regarding activities that require alertness, such as driving or operating machinery. This warning is based on the possibility of common side effects, including dizziness or fatigue, which may affect judgment or coordination.


Q: Is it required to take Cromosol at a specific time of day?

The administration schedule is based on maintaining a specific interval, such as every four to eight hours, to keep the drug concentration steady in the body. The medication does not typically require administration at a set time like morning or evening, but may be taken with food or milk to help minimize stomach discomfort.


Q: What are the main benefits of Cromosol over no treatment?

Cromosol is indicated for the symptomatic mitigation of physical pain, inflammation, and fever. The expected benefit over not receiving treatment is the reduction of these specific symptoms, helping to improve comfort and overall physical capacity.


Q: Does Cromosol interact with over-the-counter pain relievers?

Official warnings caution against combining Cromosol with other non-steroidal anti-inflammatory drugs (NSAIDs) that may be found in over-the-counter pain relief products. Taking both can increase the risk of serious gastrointestinal side effects.


Q: Do I need a prescription to get Cromosol?

The availability of Cromosol often depends on the dosage strength. Lower strengths are frequently available over-the-counter (OTC) without a prescription. However, the higher doses mentioned in the prescribing information, such as the 400 mg to 800 mg tablets, are typically available only by prescription (Rx).


Q: How quickly should I expect to see an effect from Cromosol?

Studies on the absorption of the drug indicate that it is rapidly absorbed following administration. Maximum concentration in the bloodstream is typically observed approximately one to two hours after administration.


Q: What is the average duration of action for Cromosol after a dose?

The drug has a short half-life, which is the time it takes for the body to reduce the drug concentration by half, typically around two hours. Because of this rapid clearance, the medicine is often taken multiple times daily (e.g., every four to eight hours) to maintain its therapeutic effects.


Q: Is Cromosol approved in countries outside of the US?

The active ingredient and its drug class are internationally recognized and are included on the World Health Organization's essential medicines list. Similar formulations are widely approved and available in many countries under different regulatory bodies, such as the EMA and MHRA.


Q: Does Cromosol cause weight changes?

Weight gain is not officially listed as a common side effect of the medicine. However, rapid or unexplained weight gain accompanied by swelling may be a sign of fluid retention or developing heart and kidney issues, which are serious risks associated with this type of medication.


Q: Can I take vitamins or herbal supplements while using Cromosol?

Official guidance emphasizes the importance of sharing information with a healthcare professional regarding all products currently being taken. This includes prescription and nonprescription medications, as well as vitamins, nutritional supplements, and herbal products, due to the potential for interactions or increased side effects.


Q: How long after stopping Cromosol does it stay in your system?

Due to the drug's short elimination half-life, it is processed quickly by the body. According to pharmacokinetic data, the drug is nearly completely eliminated from the system within 12 hours after the final dose in most adults.


Q: Is there a risk of dependency with Cromosol?

No. Cromosol is classified as an Anti-inflammatory Analgesic and does not belong to the class of narcotic or opioid medicines. Official safety documents do not indicate any risk of physical dependence or addiction associated with its use.


Q: Is Cromosol considered a high-risk medication?

The medication carries regulatory 'Boxed Warnings' in the official labeling. These warnings highlight the potential for serious, life-threatening cardiovascular and gastrointestinal risks that may occur at any time during treatment.


Q: What is the shelf life of Cromosol?

The shelf life refers to the time the drug can be stored while remaining safe and effective, which is indicated by the expiration date printed on the container. Official instructions specify that the medication should be used before this date, as manufacturers cannot ensure the stability or safety of expired medication.


Q: Are there any warnings about combining Cromosol with alcohol?

Regulatory warnings indicate that the consumption of alcohol should be avoided while taking this medicine. The combination significantly increases the risk of serious gastrointestinal side effects, particularly stomach bleeding.


Q: Why is it necessary to take Cromosol regularly?

The drug has a relatively short half-life, meaning the body processes and eliminates it quickly. Taking the medicine regularly, according to the prescribed frequency, is necessary to maintain a steady concentration in the bloodstream and ensure the desired therapeutic effect is achieved.

How should Cromosol be stored and disposed of?

How to Store and Dispose of Cromosol

Cromosol (Proprietary-Sone Oral Tablets) must be stored strictly according to regulatory labeling to maintain quality.

Storage Requirements

  • Temperature and Environment: Store at Controlled Room Temperature, specifically 20 C to 25 C (68 F to 77 F). The product must be protected from excessive heat and moisture.
  • Container and Protection: Keep the medication in its original container and ensure the container is tightly closed.
  • Child Safety: It is mandatory to keep the tablets out of the reach and sight of children.

Disposal Instructions

Unused or expired Cromosol should be disposed of using a drug take-back program. If a program is unavailable, mix the medicine with an unappealing substance, seal it in a plastic bag, and discard it in the household trash. Do not flush Cromosol down the toilet or pour it down a sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cromosol found in:

A-Z Index: